Skip to main content
Clinical Trials/NCT07417462
NCT07417462
Recruiting
Not Applicable

Transversus Thoracic Muscle Plane Block Versus Pectointercostal Fascial Block for Enhanced Recovery After Cardiac Surgery: A Randomized Controlled Trial

Assiut University1 site in 1 country90 target enrollmentStarted: February 18, 2026Last updated:

Overview

Phase
Not Applicable
Status
Recruiting
Enrollment
90
Locations
1
Primary Endpoint
Total amount analgesic requirement

Overview

Brief Summary

This work aims to assess the analgesic efficacies of transversus thoracic muscle plane block (TTPB) and transversus thoracic muscle plane block (TTPB) for open cardiac surgeries

Detailed Description

In patients undergoing open cardiac operation, pain management is crucial to the improved recovery. Postcardiac surgery pain is significant due to the sternotomy. The sternotomy is commonly cited as the most painful location following cardiac surgery, and postoperative pain is at its worst within the first 24 hours.

The transversus thoracic muscle plane block (TTPB) and the pectointercostal fascial block (PIFB) are new ultrasound (US)-guided regional anesthesia techniques planned to provide analgesia to the anterior thoracic wall. Both blocks primarily target the anterior cutaneous branches of the intercostal nerves (T2-T6), which are responsible for innervating the parasternal and medial anterior chest wall regions.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Outcomes Assessor)

Eligibility Criteria

Ages
40 Years to 60 Years (Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age from 40 to 60 years.
  • Both sexes.
  • American Society of Anesthesiology (ASA) physical status II-III.
  • Body mass index (BMI) \< 35 kg/m
  • Underwent cardiac surgery (coronary artery bypass graft surgery with median sternotomy).

Exclusion Criteria

  • Valve replacement procedures.
  • Emergency operations.
  • Redo surgeries.
  • Minimally invasive approaches.
  • The presence of psychiatric disorders.
  • Cognitive impairment preventing accurate assessment using the verbal numerical rating scale (NRS).
  • Known hypersensitivity or a history of allergy to local anesthetics.
  • Had severe major organ dysfunction.
  • Left ventricular ejection fraction below 30%.
  • Pregnancy or breastfeeding.

Arms & Interventions

Group PIFB

Experimental

Patients will receive pecto-intercostal fascial block intraoperatively (20 ml of bupivacaine 0.25% + 1 ml dexamethasone 8 mg).

Intervention: Pecto-intercostal fascial block (Other)

Group TTPB

Experimental

Patients will receive transversus thoracic muscle plane block was performed intraoperatively (20 ml of bupivacaine 0.25% + 1 ml dexamethasone 8 mg).

Intervention: Transversus thoracic muscle plane block (Other)

Control Group

Sham Comparator

Patients will receive bilateral superficial needle puncture at a location like transversus thoracic muscle plane block without any solution injected. Only 25 saline will be injected superficially.

Intervention: Sham (No Treatment) (Other)

Outcomes

Primary Outcomes

Total amount analgesic requirement

Time Frame: 24 hours postoperatively

In cases where rescue analgesia is required \[numerical rating scale (NRS) ≥4\], intravenous Nalbuphine 0.1 mg/kg will be given.

Secondary Outcomes

  • Degree of pain(24 hours postoperatively)
  • The number of patients required rescue analgesia(24 hours postoperatively)
  • Postoperative nausea and vomiting (PONV)(24 hours postoperatively)
  • Time to extubation(24 hours postoperatively)
  • Length of stay in the intensive care unit.(Average 7 days postoperatively)
  • Assessment of Delirium(24 hours postoperatively)
  • Level of patient satisfaction(24 hours postoperatively)
  • Incidence of complications.(7 days postoperatively)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Noha Hassan Abdel-Ghany

Lecturer of Anesthesia & ICU, Faculty of Medicine, Assiut University

Assiut University

Study Sites (1)

Loading locations...

Similar Trials